NCT06229522 Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA). Status RECRUITING Phase N/A
NCT06222008 Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution Status RECRUITING Phase N/A
NCT06215950 A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer Status RECRUITING Phase PHASE1
NCT06211023 A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT06188455 Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT06184867 Choices About Genetic Testing And Learning Your Risk With Smart Technology Status COMPLETED Phase NA
NCT06182917 Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients Status RECRUITING Phase N/A
NCT06180356 Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression Status RECRUITING Phase PHASE2
NCT06161493 ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors Status WITHDRAWN Phase PHASE1
NCT06161272 Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi Status NOT_YET_RECRUITING Phase PHASE2
NCT06145295 The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life Status COMPLETED Phase NA
NCT06139783 Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors Status NOT_YET_RECRUITING Phase NA
NCT06120972 Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency Status WITHDRAWN Phase PHASE2
NCT06120309 New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer Status ENROLLING_BY_INVITATION Phase N/A